Euronav NV (NYSE:CMBT – Get Free Report) saw a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 230,300 shares, an increase of 8.5% from the August 31st total of 212,200 shares. Currently, 1.5% of the shares of the company are short sold. Based on an average trading volume of 159,400 shares, the short-interest ratio is presently 1.4 days.
Euronav Trading Up 1.2 %
NYSE CMBT traded up $0.20 on Tuesday, reaching $16.82. 138,176 shares of the stock were exchanged, compared to its average volume of 674,189. Euronav has a one year low of $14.10 and a one year high of $21.26. The firm has a market cap of $3.39 billion, a price-to-earnings ratio of 7.45 and a beta of -0.08. The firm’s 50-day moving average price is $16.40. The company has a debt-to-equity ratio of 1.54, a current ratio of 1.37 and a quick ratio of 1.32.
Euronav (NYSE:CMBT – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.22. The firm had revenue of $233.66 million for the quarter. Euronav had a net margin of 112.38% and a return on equity of 22.35%. Sell-side analysts forecast that Euronav will post 1.46 earnings per share for the current fiscal year.
Euronav Announces Dividend
Euronav Company Profile
Euronav NV, together with its subsidiaries, engages in the transportation and storage of crude oil worldwide. The company offers floating, storage, and offloading (FSO) services. It also owns and operates a fleet of vessels. The company was incorporated in 2003 and is headquartered in Antwerp, Belgium.
Recommended Stories
- Five stocks we like better than Euronav
- How to invest in marijuana stocks in 7 steps
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Using the MarketBeat Stock Split Calculator
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Euronav Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Euronav and related companies with MarketBeat.com's FREE daily email newsletter.